DALLAS, TX / ACCESSWIRE / May 17, 2023 / Form Bio, the breakthrough computational life sciences platform, announced today that it has been selected to help organizations adopt Google Cloud's ...

SAN CARLOS, CA / ACCESS Newswire / May 11, 2026 / Form Bio, a leader in AI-powered genetic medicine development and genome engineering, today announced the launch of FormManufacturing™, a new platform ...

SAN FRANCISCO / ACCESSWIRE / June 27, 2024 / Form Bio, the provider of advanced computational life sciences technology and PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate ...

Newly Created Form Bio Raises $30M Series A Funding Led by JAZZ Venture Partners to empower life scientists with a complete platform for managing large datasets, executing verified workflows, ...

When George Church, PhD, and co-founders established Colossal Biosciences, they envisioned applying their advancements in CRISPR gene editing to the loss of biodiversity, species preservation, and ...

DALLAS--(BUSINESS WIRE)--Form Bio, the breakthrough AI-powered drug discovery platform, announced today its notable achievements and product advancements for the first half of 2023. The company’s ...

If you were tasked with resurrecting an extinct animal, where would you even begin? Colossal Biosciences, a synthetic biology company founded in 2021 by a Harvard geneticist George Church and ...

Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster. This partnership brings together GENEWIZ's industry-leading ...

Companies Form Expert Working Group to Introduce Essential Tools for AAV Development and Research Professionals SAN FRANCISCO / ACCESSWIRE / June 27, 2024 / Form Bio, the provider of advanced ...